<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:51:07Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10437504" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10437504</identifier>
        <datestamp>2023-08-18</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">7513587</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">3445</journal-id>
              <journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id>
              <journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id>
              <journal-title-group>
                <journal-title>Drug and alcohol dependence</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0376-8716</issn>
              <issn pub-type="epub">1879-0046</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10437504</article-id>
              <article-id pub-id-type="pmcid">PMC10437504</article-id>
              <article-id pub-id-type="pmc-uid">10437504</article-id>
              <article-id pub-id-type="pmid">36706675</article-id>
              <article-id pub-id-type="pmid">36706675</article-id>
              <article-id pub-id-type="doi">10.1016/j.drugalcdep.2023.109783</article-id>
              <article-id pub-id-type="manuscript">nihpa1920815</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hahn</surname>
                    <given-names>Judith A.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="CR1" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fatch</surname>
                    <given-names>Robin</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Emenyonu</surname>
                    <given-names>Nneka I.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sanyu</surname>
                    <given-names>Naomi</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Katusiime</surname>
                    <given-names>Anita</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Levine</surname>
                    <given-names>Barry</given-names>
                  </name>
                  <xref rid="A3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Boscardin</surname>
                    <given-names>W. John</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chander</surname>
                    <given-names>Geetanjali</given-names>
                  </name>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hutton</surname>
                    <given-names>Heidi</given-names>
                  </name>
                  <xref rid="A5" ref-type="aff">e</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Camlin</surname>
                    <given-names>Carol S.</given-names>
                  </name>
                  <xref rid="A6" ref-type="aff">f</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Woolf-King</surname>
                    <given-names>Sarah E.</given-names>
                  </name>
                  <xref rid="A7" ref-type="aff">g</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Muyindike</surname>
                    <given-names>Winnie R.</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>a</label>Department of Medicine, University of California, San Francisco, CA, USA</aff>
              <aff id="A2"><label>b</label>Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda</aff>
              <aff id="A3"><label>c</label>Department of Computer Science, San Francisco State University, San Francisco, CA, USA</aff>
              <aff id="A4"><label>d</label>Department of Medicine, University of Washington, Seattle, WA, USA</aff>
              <aff id="A5"><label>e</label>School of Medicine, Johns Hopkins University, Baltimore, MD, USA</aff>
              <aff id="A6"><label>f</label>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, CA, USA</aff>
              <aff id="A7"><label>g</label>College of Arts &amp; Sciences, Syracuse University, Syracuse, NY, USA</aff>
              <author-notes>
                <corresp id="CR1"><label>*</label>Corresponding author. <email>judy.hahn@ucsf.edu</email> (J.A. Hahn).</corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>4</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>01</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>21</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>18</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <volume>244</volume>
              <fpage>109783</fpage>
              <lpage>109783</lpage>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract id="ABS1">
                <sec id="S1">
                  <title>Purpose:</title>
                  <p id="P1">To test the efficacy of two interventions to reduce alcohol use and increase viral suppression compared to a control in persons with HIV (PWH).</p>
                </sec>
                <sec id="S2">
                  <title>Methods:</title>
                  <p id="P2">In a three-arm (1:1:1) randomized controlled trial (N = 269), we compared in-person counselling (45–70 minutes, two sessions over three months) with interim monthly booster phone calls (live call arm) or twice-weekly automated booster sessions (technology arm) to a brief advice control arm. We enrolled PWH self-reporting unhealthy alcohol use (Alcohol Use Disorders Identification Test – Consumption, prior three months, women ≥3, men ≥4). Primary outcomes were number of self-reported drinking days (NDD) in the prior 21 and biomarker phosphatidylethanol (PEth) at six and nine months and viral suppression (&lt;40 copies/mL) at nine months; we adjusted for sex and baseline outcomes.</p>
                </sec>
                <sec id="S3">
                  <title>Results:</title>
                  <p id="P3">At baseline, mean 21-day NDDs were 9.4 (95 % CI: 9.1–9.8), mean PEth was 407.8 ng/mL (95 % CI: 340.7–474.8), and 89.2 % were virally suppressed. At follow-up, there were significant reductions in mean NDDs for the live call versus control arm (3.5, 95 % CI:2.1–4.9, p &lt; 0.001) and for the technology versus control arm (3.6, 95 % CI: 2.2–5.1, p &lt; 0.001). The mean PEth differences compared to the control arm were not significant, i.e. 36.4 ng/mL (95 % CI: −117.5 to 190.3, p = 0.643) for the live call and −30.9 ng/mL (95 % CI: −194.8 to 132.9, p = 0.711) for the technology arm. Nine-month viral suppression compared to the control was similar in the live call and in the technology arm.</p>
                </sec>
                <sec id="S4">
                  <title>Conclusion:</title>
                  <p id="P4">Intervention effects were found on self-reported NDD but not PEth or viral suppression, suggesting no treatment effect.</p>
                  <p id="P5">(<ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT03928418" ext-link-type="uri">NCT #03928418</ext-link>)</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Brief alcohol intervention</kwd>
                <kwd>Unhealthy drinking</kwd>
                <kwd>Phosphatidylethanol</kwd>
                <kwd>Social desirability bias</kwd>
                <kwd>HIV</kwd>
                <kwd>Sub-Saharan Africa</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="S5">
              <label>1.</label>
              <title>Introduction</title>
              <p id="P6">Alcohol consumption is a critical driver of poor HIV outcomes,especially in sub-Saharan Africa (SSA), where both are extremely common (<xref rid="R12" ref-type="bibr">Hahn et al., 2011</xref>). Unhealthy alcohol use, defined as drinking above recommended limits, has been associated with reduced antiretroviral adherence, decreased HIV suppression, and increased mortality among those with HIV (<xref rid="R48" ref-type="bibr">Williams et al., 2016</xref>). Reducing unhealthy alcohol use is likely to improve HIV outcomes (<xref rid="R42" ref-type="bibr">Satre et al., 2020</xref>), and is therefore a high health priority worldwide.</p>
              <p id="P8">The vast majority of PWH live in low-income settings, thus low-cost alcohol interventions, such as brief counselling-based interventions, are needed. A meta-analysis of alcohol counselling interventions conducted among PWH worldwide, though primarily in high income countries, showed a small but significant effect on reducing total amount of alcohol consumed and on HIV viral suppression (<xref rid="R43" ref-type="bibr">Scott-Sheldon et al., 2017</xref>). However, a more recent systematic review found no consistent effect of counselling on these outcomes (<xref rid="R26" ref-type="bibr">Madhombiro et al., 2019</xref>). Few brief alcohol interventions have been examined in sub-Saharan Africa (<xref rid="R9" ref-type="bibr">Francis et al., 2019</xref>), thus there is an urgent need to investigate brief alcohol interventions for PWH in such settings.</p>
              <p id="P9">It is also unknown how best to deliver low-cost alcohol interventions in low-income settings. Multi-session interventions that combine inperson visits with booster phone calls to reinforce the in-person counseling have shown efficacy (<xref rid="R6" ref-type="bibr">Chander et al., 2015</xref>; <xref rid="R8" ref-type="bibr">Fleming et al., 1997</xref>; <xref rid="R11" ref-type="bibr">Go et al., 2020</xref>). Because cell phone use in Uganda is high, phone-based booster sessions to supplement in-person sessions may be feasible. In addition, automated cell phone-based booster sessions, previously successful in improving health behaviors (<xref rid="R17" ref-type="bibr">Hall et al., 2015</xref>), can be conducted via systems such as two-way Short Message Service (SMS, i.e. text messaging) or Interactive Voice Response (IVR) that allow for brief interactive, two-way sessions. However, the uptake, acceptability, cost, and efficacy of live and tech-based booster calls for interventions for reducing alcohol use and improving HIV outcomes in SSA is not known.</p>
              <p id="P10">Lastly, the primary outcomes for all prior brief intervention trials were measured by self-report, which may be subject to social desirability bias because participants who are counselled to reduce alcohol use may be especially vulnerable to under-reporting (<xref rid="R31" ref-type="bibr">McCambridge and Saitz, 2017</xref>). There is a need to employ objective measurement of alcohol intervention effects; the use of biomarkers such as phosphatidylethanol (PEth) has been suggested (<xref rid="R26" ref-type="bibr">Madhombiro et al., 2019</xref>).</p>
              <p id="P11">The primary aim was to conduct a three-arm randomized controlled trial (RCT) to examine the efficacy of a brief counselling-based intervention among PWH with unhealthy alcohol use in southwest Uganda. The intervention included two in-person sessions and booster sessions delivered by either monthly live counsellor phone calls or by twice-weekly automated two-way messaging. We compared each to a standard of care control at follow-up (six and nine months after baseline). Our primary outcomes were number of drinking days by self-report and PEth, and HIV viral suppression. We hypothesized that each format of the intervention would reduce alcohol use compared to the standard of care. We also examined intervention acceptability, uptake, and cost (described elsewhere).</p>
            </sec>
            <sec id="S6">
              <label>2.</label>
              <title>Methods</title>
              <sec id="S7">
                <label>2.1.</label>
                <title>Design</title>
                <p id="P12">This was a 3-arm parallel design RCT with a 1:1:1 allocation ratio.</p>
              </sec>
              <sec id="S8">
                <label>2.2.</label>
                <title>Setting</title>
                <p id="P13">The study took place in the semi-urban setting of Mbarara, Uganda. Participants were recruited from the Immune Suppression Syndrome (ISS) Clinic of the Mbarara Regional Referral Hospital (MRRH), an HIV clinic with over 11,000 active patients.</p>
              </sec>
              <sec id="S9">
                <label>2.3.</label>
                <title>Ethical approval</title>
                <p id="P14">All study procedures were approved by the institutional review boards of the University of California, San Francisco, the Mbarara University of Science and Technology, and the Uganda National Council on Science and Technology. The study was registered at <ext-link xlink:href="http://ClinicalTrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> (<ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT03928418" ext-link-type="uri">NCT #03928418</ext-link>) and followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline for multi-arm parallel group trial designs (<xref rid="R21" ref-type="bibr">Juszczak et al., 2019</xref>).</p>
              </sec>
              <sec id="S10">
                <label>2.4.</label>
                <title>Inclusion criteria</title>
                <p id="P15">Inclusion criteria were being infected with HIV, 18 years and older, Alcohol Use Disorders Identification Test – Consumption (AUDIT-C, modified to cover the prior 3 months) positive (≥3 for women, ≥4 for men); having daily access to a working cell phone (confirmed by study staff); being prescribed antiretroviral therapy (ART) for at least six months; living within a 2-hour driving distance or 60 km of the study site; and being fluent in English or Runyankole (the local language). Given the scarcity of mental health professionals in Africa (<xref rid="R41" ref-type="bibr">Sankoh et al., 2018</xref>), we included persons reporting unhealthy alcohol use, i.e. the entire spectrum of alcohol use that is harmful to health (<xref rid="R40" ref-type="bibr">Saitz et al., 2021</xref>). Persons who planned to move out of the catchment area within six months, were participating in another research study, or were unable to give informed consent, were excluded.</p>
              </sec>
              <sec id="S11">
                <label>2.5.</label>
                <title>Recruitment</title>
                <p id="P16">We screened clinic patients who had reported any alcohol use via the AUDIT in their intake clinic visits or by clinic staff knowledge. All participants gave written informed consent to participate in the study in either English or Runyankole.</p>
              </sec>
              <sec id="S12">
                <label>2.6.</label>
                <title>Randomization and masking</title>
                <p id="P17">Following baseline questionnaires and blood draw, we randomized participants to: (1) in-person brief workbook-based alcohol counseling at two regularly-scheduled quarterly clinic visits plus interim boosters delivered every 3 weeks by phone (live call arm); (2) in-person brief workbook-based alcohol counseling at two regularly-scheduled quarterly clinic visits plus twice-weekly boosters delivered via two-way automated calls either by SMS or IVR (technology arm); or (3) standard of care which included brief advice, with a wait-listed intervention (control arm). We created a computer-generated randomization list with a 1:1:1 ratio using blocks of nine for pre-printing on scratch cards that the participants scratched with a coin to reveal the randomization arm to themselves and the study staff. There was no masking of study arm. Those randomized to the intervention arms were referred to the study counselor for in-person counseling and training on the booster calls. Those randomized to the control arm had no contact with the study counselors during the first nine months of the study, but were offered the study intervention after their nine-month study visit.</p>
              </sec>
              <sec id="S13">
                <label>2.7.</label>
                <title>Interventions</title>
                <p id="P18">The in-person one-on-one counseling sessions, administered by a lay health-counselor in both intervention arms, were conducted in a private room at the clinic using an illustrated workbook. Before the trial, we adapted the workbook from a prior study (<xref rid="R6" ref-type="bibr">Chander et al., 2015</xref>) for PWH in Uganda (<xref rid="R24" ref-type="bibr">Leddy et al., 2021</xref>). The sessions were originally 20-minutes each, but local communication styles required deprioritizing brevity. The illustrated workbook includes health assessments, discussions of the harms related to drinking, feedback on levels of drinking, discussion of strategies to reduce drinking, and an agreement form for negotiated maximum drinking, that reflected a reduction in the number of drinks per day, days drinking, or both. Participants were given the workbook and a fillable illustrated drinking diary to take home, and were asked to bring a friend or relative to help support them with their drinking goals to their second counseling session. The second session, scheduled to coincide with the participants’ next clinic visit three months later, included reinforcement of the drinking goals and discussion of challenges to reducing drinking, and support person advise on helping the participants with their goals.</p>
                <p id="P19">Booster sessions, tailored to participants’ drinking agreements and gender, occurred between the two in-person sessions, and were scripted in both intervention arms to check participants’ progress on meeting the drinking agreement, and to provide positive reinforcement when drinking limits were achieved, and encouragement to keep trying when they were not met. The booster calls also allowed for a revision of participants’ drinking goals. Technology arm participants were asked to choose between SMS and IVR for their booster delivery after both were demonstrated by the intervention counselor. The IVR boosters, recorded in the voices of the actual counselors, included simple yes/no responses to recorded questions and were included to account for the expected low literacy of some of the participants. The technology boosters also included the option to request a call back from a live counselor. The live call boosters were delivered every 3 weeks and the technology boosters were delivered twice weekly. Following the first in-person session, the counselors trained the participants in the technology arm on entering a personal identification number to obtain the messages and responding to the booster session questions, with repeated training as needed, and provided a toll-free phone line to contact study staff.</p>
                <p id="P20">The counsellors were Ugandan graduates of college and the Uganda Ministry of Health HIV counselor training. For this study, they received approximately 10 hours of training and monthly check-ins with a licensed clinical psychologist with experience in Motivational Interviewing (MI) and brief alcohol interventions (SWK). The training included readings on MI, review of the intervention workbook, and multiple structured role-plays of the intervention.</p>
              </sec>
              <sec id="S14">
                <label>2.8.</label>
                <title>Fidelity</title>
                <p id="P21">We audio-recorded the in-person counseling sessions and the Ugandan study coordinator reviewed 15 % of them for fidelity (n = 37), using a 17-item check-list of intervention components adapted to the current trial (<xref rid="R35" ref-type="bibr">Pantalon et al., 2012</xref>) and assessing the skills of the counsellors in the use of empathy, non-judgmental style, encouragement, warmth, and open-ended questions (<xref rid="R44" ref-type="bibr">Singla et al., 2014</xref>).</p>
              </sec>
              <sec id="S15">
                <label>2.9.</label>
                <title>Adaptations for COVID-19</title>
                <p id="P22">On March 30, 2020, the Ugandan government issued restrictions on movement that lasted until May 22, 2020. During that time, we ceased in-person study visits. At the start of the restrictions, 31 persons were enrolled and had completed session one only. To avoid in-person contact, we extended delivery of booster sessions, resulting in a mean time between sessions of 3.8 months (95 % CI: 3.6–4.1) for those 31 participants, compared to 2.8 months (95 % CI: 2.8–2.9) in those enrolled after restrictions were lifted.</p>
              </sec>
              <sec id="S16">
                <label>2.10.</label>
                <title>Assessments</title>
                <p id="P23">We conducted a structured interviewer-administered questionnaire at baseline, six, and nine months. The baseline questionnaire included demographics and literacy (<xref rid="R33" ref-type="bibr">Morris et al., 2006</xref>), and all questionnaires included the 30-day Timeline Follow Back (TLFB)(<xref rid="R45" ref-type="bibr">Sobell and Sobell, 1992</xref>), the AUDIT-C (<xref rid="R5" ref-type="bibr">Bradley et al., 2007</xref>), adapted to reflect the prior three months, and the Marlowe Crowne social desirability scale (SDS, observed alpha=0.68)(<xref rid="R7" ref-type="bibr">Crowne and Marlowe, 1960</xref>). We used pictures of local drinks to define standard drinks. At six months, we also asked the Client Satisfaction Scale (<xref rid="R3" ref-type="bibr">Attkisson and Greenfield, 2004</xref>) (observed alpha=0.66) and the System Usability Scale (<xref rid="R4" ref-type="bibr">Bangor et al., 2008</xref>) (technology arm only, observed alpha=0.68). We included the Perceived Awareness of the Research Hypothesis scale (<xref rid="R38" ref-type="bibr">Rubin, 2016</xref>) (observed alpha=0.41), but due to low reliability we used our own question about the purpose of the research (“To find ways to reduce alcohol use”). At three months, we conducted the TLFB. All questionnaire items were translated into Runyankole and back-translated, and were offered in English and Runyankole. Participants were provided transport refunds, a meal, and a bar of soap at each study visit.</p>
              </sec>
              <sec id="S17">
                <label>2.11.</label>
                <title>Laboratory testing</title>
                <p id="P24">We conducted venous blood draws at each study visit. We prepared dried blood spots (DBS) by pipetting 5 μL spots onto Whatman 903 cards. DBS cards were stored at −80 C and shipped in batches to a commercial laboratory for PEth quantification (16:0/18:1 analog), with limit of quantification (LOQ) of 8 ng/mL (<xref rid="R20" ref-type="bibr">Jones et al., 2011</xref>). PEth has been shown to decline to undetectable levels after drinking ceases (<xref rid="R10" ref-type="bibr">Gnann et al., 2012</xref>), and is well-correlated with the volume of alcohol consumed over the past 2–4 weeks (<xref rid="R46" ref-type="bibr">Ulwelling and Smith, 2018</xref>). Due to recent findings of an association of PEth sensitivity with anemia and body mass index (BMI)(<xref rid="R16" ref-type="bibr">Hahn et al., 2021</xref>), hemoglobin and BMI were measured at the baseline, six, and nine-month visits. Viral load testing was performed using Gene Xpert at baseline and nine months.</p>
              </sec>
              <sec id="S18">
                <label>2.12.</label>
                <title>Primary outcomes</title>
                <p id="P25">The primary outcomes were number of days drinking (NDD) alcohol in the prior 21 (calculated from the 30-day TLFB) and PEth at the six- and nine-month study visits, together, and viral suppression (&lt;40 copies/mL) at nine months. We chose NDD to be consistent with a similar intervention (<xref rid="R6" ref-type="bibr">Chander et al., 2015</xref>), and because this measure was most highly correlated with PEth in Uganda (<xref rid="R13" ref-type="bibr">Hahn et al., 2012</xref>). In addition, NDD is more reliable than number of standard drinks, which is challenging to measure due to a wide range of drink sizes and concentrations and beverage sharing in Uganda. We chose a 21-day period to be consistent with the window of detection for PEth (<xref rid="R14" ref-type="bibr">Hahn et al., 2016a</xref>).</p>
              </sec>
              <sec id="S19">
                <label>2.13.</label>
                <title>Secondary outcomes</title>
                <p id="P26">Additional outcomes were the number of heavy drinking days (&gt;3 drinks per day for women and &gt;4 drinks per day for men) in the prior 21 days, the AUDIT-C score (0–12), unhealthy alcohol consumption (AUDIT-C positive), PEth ≥ 50 ng/mL (consistent with unhealthy drinking) (<xref rid="R15" ref-type="bibr">Hahn et al., 2016b</xref>), and a composite measure of unhealthy alcohol use (AUDIT-C positive and/or PEth≥50 ng/mL), referred to as AUDIT-C/PEth. We also examined self-reported ART adherence (percent adherent, measured using the lower of a 30-day visual analog scale and the number of days in the prior 30 the participant reported missed pills) and the SDS score. We intended to examine CD4 cell counts extracted from clinic records, but were unable to, because the MRRH ISS Clinic discontinued CD4 testing when viral load monitoring became routine.</p>
              </sec>
              <sec id="S20">
                <label>2.14.</label>
                <title>Statistical methods</title>
                <sec id="S21">
                  <label>2.14.1.</label>
                  <title>Primary outcomes</title>
                  <p id="P27">We calculated summary statistics (proportions, means, and 95 % confidence intervals [CIs]) at baseline and follow up, overall and by randomization arm. For the primary analyses, we used mixed effects modeling of the follow up time points, using Intention to Treat. The models included random effects for participants, and fixed effects for timepoint (dummy variable for 6 or 9 month), study arm, and the interaction of time and study arm, as well as patient sex and the baseline outcome measurement (i.e. NDD, PEth, or viral suppression). We used the negative binomial distribution for NDD as recommended for alcohol use outcomes (<xref rid="R18" ref-type="bibr">Horton et al., 2007</xref>), and linear modeling for log10 transformed PEth (setting transformed values below the LOQ to 0), due to its skewness. In order to directly report adjusted mean values for PEth we estimated a generalized linear model with gamma distribution and log link as is commonly used to model right skewed distributions (<xref rid="R30" ref-type="bibr">Manning and Mullahy, 2001</xref>). The generalized linear models yielded the same conclusions as the linear models. We conducted logistic regression for viral suppression at nine months, controlling for sex and baseline viral suppression.</p>
                  <p id="P28">We conducted sensitivity analyses to examine the effect of missing follow-up observations, by setting missing data points to the baseline value. We examined effect modification of the treatment effect for both outcomes by sex, baseline NDD (median split), baseline PEth (median split), self-reported very high-risk alcohol use (baseline AUDIT-C≥8, based on literature showing this cutoff indicated high mean alcohol consumption (<xref rid="R39" ref-type="bibr">Rubinsky et al., 2013</xref>)), literacy, and whether each study visit occurred before versus after the implementation of COVID-19 movement restrictions (March 30, 2020), and conducted stratified analyses when interaction was observed (p &lt; 0.100).</p>
                </sec>
                <sec id="S22">
                  <label>2.14.2.</label>
                  <title>Secondary outcomes and post-hoc analyses</title>
                  <p id="P29">We constructed additional models for the secondary outcomes, using the logit link for binary outcomes, negative binomial distribution for count outcomes, and linear models for continuous outcomes, controlling for sex and the baseline level of the outcome variable. Our mixed model for the composite AUDIT-C/PEth variable did not converge; we instead conducted a generalized estimating equation (GEE) logistic regression model. We conducted an analysis of SDS score, to examine whether SDS increased over time in study and whether changes in SDS over time were differential by study arm. To explore discordance between self-report and PEth results, we constructed a model of NDD, including the study arm by follow-up interaction, sex, PEth (log10 ng/mL), SDS score, and the Perceived Awareness of the Research Hypothesis scale as the independent variables. We did not correct for multiple comparisons given guidance against doing so (<xref rid="R21" ref-type="bibr">Juszczak et al., 2019</xref>).</p>
                  <p id="P30">We conducted two post-hoc exploratory analyses: 1) adding BMI and anemia to the main model of log10 PEth described above, and 2) excluding the subset of participants with BMI≥ 30 and severe anemia for whom PEth was previously observed to be less sensitive from our main log10 PEth model (<xref rid="R16" ref-type="bibr">Hahn et al., 2021</xref>).</p>
                </sec>
                <sec id="S23">
                  <label>2.14.3.</label>
                  <title>Sample size</title>
                  <p id="P31">The a priori sample size calculation assumed 90 % follow-up retention and used a simplifying t-test for power calculations. We found that a sample size of 90 per study arm, chosen for logistical feasibility, would yield 80 % power to detect a difference in the number of drinking days in the prior 21 between two study arms at follow up of ≥ 2.4 days, i.e. nearly 1 fewer day per week, as statistically significant (α = 0.05) assuming that the mean number of drinking days in the prior 21 in the control group at six months would be 7, based on prior data.</p>
                </sec>
              </sec>
            </sec>
            <sec id="S24">
              <label>3.</label>
              <title>Results</title>
              <sec id="S25">
                <label>3.1.</label>
                <title>Enrollment and retention</title>
                <p id="P32">From September 19, 2019 through December 20, 2020, 994 persons were approached, 321 were eligible, and 270 were randomized (<xref rid="F1" ref-type="fig">Fig. 1</xref>). After enrollment was completed, one person was found to be enrolled and randomized twice to the control arm; the initial enrollment was retained, so n = 269. Follow-up at six and nine months was 92–94 % in the live call arm, 96–97 % in the technology arm, and 94–96 % in the control arm (<xref rid="F1" ref-type="fig">Fig. 1</xref>). Data were complete for NDDs, but one six-month visit (control arm) was missing a PEth test, and eight nine-month visits (five in the live call arm, three in the technology arm) were missing viral load results due to laboratory failure. There was one adverse event in which a participant reported suicidal thoughts, considered unrelated to study participation, that resolved after referral to a psychiatrist.</p>
                <p id="P33">Two-thirds (65.4 %) of the participants were male and the mean age was 40.2 (95 % CI: 39.1–41.3)(<xref rid="T1" ref-type="table">Table 1</xref>). The mean number of self-reported drinking days at baseline was 9.4 (95 % CI: 9.1–9.8), mean PEth was 407.8 ng/mL (95 % CI: 340.7–474.8), and 89.2 % were virally suppressed at baseline.</p>
              </sec>
              <sec id="S26">
                <label>3.2.</label>
                <title>Intervention adherence and satisfaction</title>
                <p id="P34">All participants in the intervention arms completed the first in-person session, and 97.8 % of persons in the live counselling arm and 94.4 % of participants in the technology arm completed session 2 (<xref rid="T2" ref-type="table">Table 2</xref>). The mean length of session 1 was 69.8 min (95 % CI: 68.2–71.4), and the mean length of session 2 was 43.8 min (95 % CI: 41.9–45.7). In the live counselor arm, a mean of 86.5 % (95 % CI: 81.8–91.3) of scheduled booster calls were completed, 44.7 % (95 % CI: 33.4–51.1) of scheduled technology booster sessions were completed. The intervention fidelity and counselling skills were high (&gt;95 % scores), as were satisfaction and usability.</p>
              </sec>
              <sec id="S27">
                <label>3.3.</label>
                <title>Primary outcomes</title>
                <p id="P35">The unadjusted means for NDDs and PEth by study month are presented (<xref rid="F2" ref-type="fig">Fig. 2</xref> and <xref rid="T3" ref-type="table">Table 3</xref>). We found significant differences in NDDs in the intervention arms at follow-up (six and nine months) compared to the control, i.e. the adjusted mean reduction in NDDs was 3.5 days (95 % CI: 2.1–4.9, p &lt; 0.001) in the live call compared to the control arm and 3.6 days (95 % CI: 2.2–5.1, p &lt; 0.001) in the technology arm compared to the control arm (<xref rid="T4" ref-type="table">Table 4</xref>). There were no significant differences in follow-up PEth or viral suppression for either intervention arm compared to the control.</p>
                <p id="P36">We found no evidence of effect modification by sex, baseline alcohol use (above or below the median NDD, PEth, and AUDIT-C≥8), baseline social desirability score (above or below the median), and whether the study visit occurred before or after the COVID-19 restrictions were instituted (p &gt; 0.200, data not shown). There was an interaction of literacy with treatment effects for the NDD outcome (p = 0.05); we found that the treatment effects measured by NDD persisted in both literacy strata, but were stronger in the low literacy group (data not shown). We reached the same conclusions when we included missing data at follow-up as their baseline values in sensitivity analyses (data not shown). The intervention effects on PEth did not differ substantially when we adjusted for BMI and anemia, nor when those with high BMI or anemia (n = 44) were excluded from the analyses (data not shown).</p>
              </sec>
              <sec id="S28">
                <label>3.4.</label>
                <title>Secondary outcomes and exploratory analyses</title>
                <p id="P37">The results for secondary alcohol outcome measures were consistent with the main findings. We observed statistically significant decreases in both intervention arms compared to the control at follow up when measured by self-reported number of heavy drinking days, AUDIT-C score, and unhealthy alcohol use by AUDIT-C (<xref rid="T5" ref-type="table">Tables 5</xref> and <xref rid="T6" ref-type="table">6</xref>). We observed no significant decreases in the proportion with PEth≥ 50 ng/mL in the intervention arms compared to the control. When we used the composite AUDIT-C/PEth variable for unhealthy alcohol use, we found an effect at follow up of the live call arm compared to the control that did not reach statistical significance (p = 0.063). We found no differences in the intervention arms compared to the control in self-reported prior 30-day ART adherence.</p>
                <p id="P38">SDS appeared to increase over study month (<xref rid="T5" ref-type="table">Table 5</xref>), however we found no significant differences in SDS between each intervention arm and the control (<xref rid="T6" ref-type="table">Table 6</xref>). In exploratory analyses, we found an association of SDS with NDD, with a 1-point increase in SDS associated with an 3 % decrease in the reported NDD, but this did not reach statistical significance (p = 0.067, data not shown). Awareness of the study aim to reduce alcohol use was high (71.1 %) and not associated with NDDs (data not shown).</p>
              </sec>
            </sec>
            <sec id="S29">
              <label>4.</label>
              <title>Discussion</title>
              <p id="P39">We compared two versions of a brief multi-session alcohol intervention targeted to PWH with unhealthy alcohol use adapted for the Ugandan context (<xref rid="R24" ref-type="bibr">Leddy et al., 2021</xref>) to a control condition, and found significant intervention effects when measured by self-reported alcohol use, but no effects when measured by PEth, a well validated alcohol biomarker (<xref rid="R10" ref-type="bibr">Gnann et al., 2012</xref>). The mean PEth follow-up levels were well above 200 ng/mL, a cutoff for chronic excessive alcohol use (<xref rid="R25" ref-type="bibr">Luginbühl et al., 2022</xref>). Thus, we conclude that there was no significant intervention effect on alcohol use despite the self-reported effect. We also failed to find effects on viral suppression. This study occurred concurrently with the start of the COVID-19 pandemic, which was a stressful time; we found in another study that alcohol consumption increased in PWH in southwest Uganda, despite government-ordered bar closures (<xref rid="R2" ref-type="bibr">Asiimwe et al., 2022</xref>). It is plausible that the effects of the pandemic overwhelmed any intervention effects that might have otherwise occurred.</p>
              <p id="P40">We suspect that the self-reported decreases in alcohol use were at least in part due to social desirability, as SDS scores increased over the study period. In qualitative interviews conducted after the intervention (manuscript under review), participants reported feeling personally cared for by the study staff and counselors, motivated to reduce their alcohol use, and feeling shame when staff asked them whether they had reduced their drinking if they had not. The differences in results when measured by self-report versus PEth are consistent with discrepancies found in observational studies of PWH in Uganda (<xref rid="R1" ref-type="bibr">Adong et al., 2019</xref>; <xref rid="R15" ref-type="bibr">Hahn et al., 2016b</xref>; <xref rid="R28" ref-type="bibr">Magidson et al., 2019</xref>; <xref rid="R34" ref-type="bibr">Muyindike et al., 2017</xref>) and in intervention trials among PWH in Kenya (<xref rid="R36" ref-type="bibr">Papas et al., 2016</xref>) and the USA (<xref rid="R32" ref-type="bibr">McGinnis et al., 2021</xref>).</p>
              <p id="P41">Prior trials of the efficacy of counselling-based alcohol interventions for PWH on alcohol use have shown either small or inconclusive intervention efficacy (<xref rid="R26" ref-type="bibr">Madhombiro et al., 2019</xref>; <xref rid="R43" ref-type="bibr">Scott-Sheldon et al., 2017</xref>); results of studies conducted among PWH in sub-Saharan Africa have also been mixed (<xref rid="R19" ref-type="bibr">Huis In ‘t Veld et al., 2019</xref>; <xref rid="R22" ref-type="bibr">Kane et al., 2022</xref>; <xref rid="R27" ref-type="bibr">Madhombiro et al., 2020</xref>; <xref rid="R29" ref-type="bibr">Magidson et al., 2021</xref>; <xref rid="R37" ref-type="bibr">Papas et al., 2021</xref>; <xref rid="R47" ref-type="bibr">Wandera et al., 2016</xref>). The previous findings are based on self-report; to dispel uncertainty, we recommend that future alcohol intervention studies among PWH use PEth alone or combined with self-report as the primary outcome.</p>
              <p id="P42">The primary strengths of this study are that we measured PEth, and we had high follow-up rates. We were limited in our ability to study the impact of the interventions on viral suppression because viral non-suppression, which is low in Uganda (10 %) (<xref rid="R23" ref-type="bibr">Lecher et al., 2021</xref>) was not an eligibility criterion, and the study power calculations were not based on this outcome. In addition, the high proportion with viral suppression suggests that improving HIV health may not have been a motivator for reducing alcohol use. We were also limited in our ability to prevent contamination across study arms; however, we felt the likelihood of this was low because the intervention occurred at a large HIV clinic (with approximately 150 patients seen per day). Our findings may have been limited by not excluding persons with severe alcohol use disorder; however, the lack of effect modification by high-risk alcohol use at baseline suggests this was not a major factor. The single site and the occurrence of a global pandemic limit the generalizability of our findings.</p>
              <p id="P43">In summary, while we found effects on self-reported alcohol use, we found no effects on PEth, indicating that neither version of this brief intervention was sufficient to substantially impact alcohol use. Because unhealthy alcohol use causes multiple co-morbidities to PWH (<xref rid="R48" ref-type="bibr">Williams et al., 2016</xref>), there is urgent need for further work to reduce alcohol use among PWH. We urge further work to develop effective screening and interventions that can be feasibly integrated into HIV and other chronic disease care. Other interventions should also be examined, including the use of pharmacologic methods, transdiagnostic interventions that target the underlying processes that drive unhealthy alcohol use, and incentive-based interventions, with attention paid to the feasibility of implementation in low-resource settings. In HIV care, future interventions should focus on those populations at highest risk, such as those missing clinic visits or not attaining viral suppression. The discrepancy we observed between self-report and PEth also highlights the urgent need to use objective measures as primary outcomes in future behavioral trials in PWH.</p>
            </sec>
          </body>
          <back>
            <ack id="S30">
              <title>Acknowledgements</title>
              <p id="P44">The authors would like to acknowledge the hard work of the Extend Team study staff, especially the counsellors and research assistants. We also thank the study participants for their time and participation. We dedicate this manuscript to the fond memory of Dr. Richard Saitz.</p>
              <sec id="S31">
                <title>Role of funding source</title>
                <p id="P45">This work is funded by National Institutes of Health, National Institute of Alcohol Abuse and Alcoholism, Grant #R01 AA024990 and #K24 AA022586.</p>
              </sec>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement" id="FN1">
                <p id="P46">Conflict of interest</p>
                <p id="P47">Dr. Hahn received consulting fees from Pear Therapeutics in 2022.</p>
              </fn>
            </fn-group>
            <glossary>
              <title>Abbreviations:</title>
              <def-list>
                <def-item>
                  <term>PEth</term>
                  <def>
                    <p id="P48">Phosphatidylethanol</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PWH</term>
                  <def>
                    <p id="P49">Persons with HIV</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <mixed-citation publication-type="journal"><name><surname>Adong</surname><given-names>J</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Cheng</surname><given-names>DM</given-names></name>, <name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Ngabirano</surname><given-names>C</given-names></name>, <name><surname>Kekibiina</surname><given-names>A</given-names></name>, <name><surname>Woolf-King</surname><given-names>SE</given-names></name>, <name><surname>Samet</surname><given-names>JH</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <year>2019</year>. <article-title>Social desirability bias impacts self-reported alcohol use among persons with HIV in Uganda</article-title>. <source>Alcohol Clin. Exp. Res</source></mixed-citation>
              </ref>
              <ref id="R2">
                <mixed-citation publication-type="journal"><name><surname>Asiimwe</surname><given-names>C</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Cheng</surname><given-names>DM</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Ngabirano</surname><given-names>C</given-names></name>, <name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <year>2022</year>. <article-title>Bar attendance and alcohol use before and after COVID-19 related restrictions among HIV-infected adults in South-Western Uganda</article-title>. <source>AIDS Behav</source>. <fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
              </ref>
              <ref id="R3">
                <mixed-citation publication-type="book"><name><surname>Attkisson</surname><given-names>CC</given-names></name>, <name><surname>Greenfield</surname><given-names>TK</given-names></name>, <year>2004</year>. <source>The UCSF client satisfaction scales: I. The client satisfaction questionnaire-8. In: The use of psychological testing for treatment planning and outcomes assessment: Instruments for adults</source>, <edition>3rd ed.</edition>,, Volume <volume>3</volume>. <publisher-name>Lawrence Erlbaum Associates Publishers</publisher-name>,, <publisher-loc>Mahwah, NJ, US</publisher-loc>, pp. <fpage>799</fpage>–<lpage>811</lpage>.</mixed-citation>
              </ref>
              <ref id="R4">
                <mixed-citation publication-type="journal"><name><surname>Bangor</surname><given-names>A</given-names></name>, <name><surname>Kortum</surname><given-names>PT</given-names></name>, <name><surname>Miller</surname><given-names>JT</given-names></name>, <year>2008</year>. <article-title>An empirical evaluation of the system usability scale</article-title>. <source>Int. J. Hum. Interact</source><volume>24</volume> (<issue>6</issue>), <fpage>574</fpage>–<lpage>594</lpage>.</mixed-citation>
              </ref>
              <ref id="R5">
                <mixed-citation publication-type="journal"><name><surname>Bradley</surname><given-names>KA</given-names></name>, <name><surname>DeBenedetti</surname><given-names>AF</given-names></name>, <name><surname>Volk</surname><given-names>RJ</given-names></name>, <name><surname>Williams</surname><given-names>EC</given-names></name>, <name><surname>Frank</surname><given-names>D</given-names></name>, <name><surname>Kivlahan</surname><given-names>DR</given-names></name>, <year>2007</year>. <article-title>AUDIT-C as a brief screen for alcohol misuse in primary care</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>31</volume> (<issue>7</issue>), <fpage>1208</fpage>–<lpage>1217</lpage>.<pub-id pub-id-type="pmid">17451397</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <mixed-citation publication-type="journal"><name><surname>Chander</surname><given-names>G</given-names></name>, <name><surname>Hutton</surname><given-names>HE</given-names></name>, <name><surname>Lau</surname><given-names>B</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>McCaul</surname><given-names>ME</given-names></name>, <year>2015</year>. <article-title>Brief intervention decreases drinking frequency in HIV-infected, heavy drinking women: results of a randomized controlled trial</article-title>. <source>J. Acquir Immune Defic. Syndr</source><volume>70</volume> (<issue>2</issue>), <fpage>137</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">25967270</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <mixed-citation publication-type="journal"><name><surname>Crowne</surname><given-names>DP</given-names></name>, <name><surname>Marlowe</surname><given-names>D</given-names></name>, <year>1960</year>. <article-title>A new scale of social desirability independent of psychopathology</article-title>. <source>J. Consult. Psychol</source><volume>24</volume> (<issue>4</issue>), <fpage>349</fpage>–<lpage>354</lpage>.<pub-id pub-id-type="pmid">13813058</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <mixed-citation publication-type="journal"><name><surname>Fleming</surname><given-names>MF</given-names></name>, <name><surname>Barry</surname><given-names>KL</given-names></name>, <name><surname>Manwell</surname><given-names>LB</given-names></name>, <name><surname>Johnson</surname><given-names>K</given-names></name>, <name><surname>London</surname><given-names>R</given-names></name>, <year>1997</year>. <article-title>Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices</article-title>. <source>Jama</source><volume>277</volume> (<issue>13</issue>), <fpage>1039</fpage>–<lpage>1045</lpage>.<pub-id pub-id-type="pmid">9091691</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <mixed-citation publication-type="journal"><name><surname>Francis</surname><given-names>JM</given-names></name>, <name><surname>Cook</surname><given-names>S</given-names></name>, <name><surname>Morojele</surname><given-names>NK</given-names></name>, <name><surname>Swahn</surname><given-names>MH</given-names></name>, <year>2019</year>. <article-title>Rarity and limited geographical coverage of individual level alcohol interventions in sub Saharan Africa: findings from a scoping review</article-title>. <source>J. Subst. Use</source></mixed-citation>
              </ref>
              <ref id="R10">
                <mixed-citation publication-type="journal"><name><surname>Gnann</surname><given-names>H</given-names></name>, <name><surname>Weinmann</surname><given-names>W</given-names></name>, <name><surname>Thierauf</surname><given-names>A</given-names></name>, <year>2012</year>. <article-title>Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>36</volume> (<issue>9</issue>), <fpage>1507</fpage>–<lpage>1511</lpage>.<pub-id pub-id-type="pmid">22458353</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <mixed-citation publication-type="journal"><name><surname>Go</surname><given-names>VF</given-names></name>, <name><surname>Hutton</surname><given-names>HE</given-names></name>, <name><surname>Ha</surname><given-names>TV</given-names></name>, <name><surname>Chander</surname><given-names>G</given-names></name>, <name><surname>Latkin</surname><given-names>CA</given-names></name>, <name><surname>Mai</surname><given-names>NVT</given-names></name>, <name><surname>Quynh</surname><given-names>BX</given-names></name>, <name><surname>Nguyen</surname><given-names>V</given-names></name>, <name><surname>Sripaipan</surname><given-names>T</given-names></name>, <name><surname>Lancaster</surname><given-names>KE</given-names></name>, <name><surname>Blackburn</surname><given-names>N</given-names></name>, <name><surname>Hershow</surname><given-names>RB</given-names></name>, <name><surname>Dowdy</surname><given-names>DW</given-names></name>, <name><surname>Frangakis</surname><given-names>C</given-names></name>, <year>2020</year>. <article-title>Effect of 2 integrated interventions on alcohol abstinence and viral suppression among vietnamese adults with hazardous alcohol use and HIV: a randomized clinical trial</article-title>. <source>JAMA Netw. Open</source><volume>3</volume> (<issue>9</issue>), <fpage>e2017115</fpage>.<pub-id pub-id-type="pmid">32945875</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <mixed-citation publication-type="journal"><name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Woolf-King</surname><given-names>SE</given-names></name>, <name><surname>Muyindike</surname><given-names>W</given-names></name>, <year>2011</year>. <article-title>Adding fuel to the fire: alcohol’s effect on the HIV epidemic in Sub-Saharan Africa</article-title>. <source>Curr. HIV/AIDS Rep</source><volume>8</volume> (<issue>3</issue>), <fpage>172</fpage>–<lpage>180</lpage>.<pub-id pub-id-type="pmid">21713433</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <mixed-citation publication-type="journal"><name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Dobkin</surname><given-names>LM</given-names></name>, <name><surname>Mayanja</surname><given-names>B</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Kigozi</surname><given-names>IM</given-names></name>, <name><surname>Shiboski</surname><given-names>S</given-names></name>, <name><surname>Bangsberg</surname><given-names>DR</given-names></name>, <name><surname>Gnann</surname><given-names>H</given-names></name>, <name><surname>Weinmann</surname><given-names>W</given-names></name>, <name><surname>Wurst</surname><given-names>FM</given-names></name>, <year>2012</year>. <article-title>Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>36</volume> (<issue>5</issue>), <fpage>854</fpage>–<lpage>862</lpage>.<pub-id pub-id-type="pmid">22150449</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <mixed-citation publication-type="journal"><name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Anton</surname><given-names>RF</given-names></name>, <name><surname>Javors</surname><given-names>MA</given-names></name>, <year>2016a</year>. <article-title>The formation, elimination, interpretation, and future research needs of phosphatidylethanol for research studies and clinical practice</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>40</volume> (<issue>11</issue>), <fpage>2292</fpage>–<lpage>2295</lpage>.<pub-id pub-id-type="pmid">27716960</pub-id></mixed-citation>
              </ref>
              <ref id="R15">
                <mixed-citation publication-type="journal"><name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Kekiibina</surname><given-names>A</given-names></name>, <name><surname>Carrico</surname><given-names>AW</given-names></name>, <name><surname>Woolf-King</surname><given-names>S</given-names></name>, <name><surname>Shiboski</surname><given-names>S</given-names></name>, <year>2016b</year>. <article-title>Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report</article-title>. <source>Addiction</source><volume>111</volume> (<issue>2</issue>), <fpage>272</fpage>–<lpage>279</lpage>.<pub-id pub-id-type="pmid">26381193</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <mixed-citation publication-type="journal"><name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Murnane</surname><given-names>PM</given-names></name>, <name><surname>Vittinghoff</surname><given-names>E</given-names></name>, <name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Chamie</surname><given-names>G</given-names></name>, <name><surname>Haberer</surname><given-names>JE</given-names></name>, <name><surname>Francis</surname><given-names>JM</given-names></name>, <name><surname>Kapiga</surname><given-names>S</given-names></name>, <name><surname>Jacobson</surname><given-names>K</given-names></name>, <name><surname>Myers</surname><given-names>B</given-names></name>, <name><surname>Couture</surname><given-names>MC</given-names></name>, <name><surname>DiClemente</surname><given-names>RJ</given-names></name>, <name><surname>Brown</surname><given-names>JL</given-names></name>, <name><surname>So-Armah</surname><given-names>K</given-names></name>, <name><surname>Sulkowski</surname><given-names>M</given-names></name>, <name><surname>Marcus</surname><given-names>GM</given-names></name>, <name><surname>Woolf-King</surname><given-names>S</given-names></name>, <name><surname>Cook</surname><given-names>RL</given-names></name>, <name><surname>Richards</surname><given-names>VL</given-names></name>, <name><surname>Molina</surname><given-names>P</given-names></name>, <name><surname>Ferguson</surname><given-names>T</given-names></name>, <name><surname>Welsh</surname><given-names>D</given-names></name>, <name><surname>Piano</surname><given-names>MR</given-names></name>, <name><surname>Phillips</surname><given-names>SA</given-names></name>, <name><surname>Stewart</surname><given-names>S</given-names></name>, <name><surname>Afshar</surname><given-names>M</given-names></name>, <name><surname>Page</surname><given-names>K</given-names></name>, <name><surname>McGinnis</surname><given-names>K</given-names></name>, <name><surname>Fiellin</surname><given-names>DA</given-names></name>, <name><surname>Justice</surname><given-names>AC</given-names></name>, <name><surname>Bryant</surname><given-names>K</given-names></name>, <name><surname>Saitz</surname><given-names>R</given-names></name>, <year>2021</year>. <article-title>Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: an individual patient data meta-analysis</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>45</volume> (<issue>6</issue>), <fpage>1166</fpage>–<lpage>1187</lpage>.<pub-id pub-id-type="pmid">33837975</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <mixed-citation publication-type="journal"><name><surname>Hall</surname><given-names>AK</given-names></name>, <name><surname>Cole-Lewis</surname><given-names>H</given-names></name>, <name><surname>Bernhardt</surname><given-names>JM</given-names></name>, <year>2015</year>. <article-title>Mobile text messaging for health: a systematic review of reviews</article-title>. <source>Annu. Rev. Public Health</source><volume>36</volume>, <fpage>393</fpage>–<lpage>415</lpage>.<pub-id pub-id-type="pmid">25785892</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <mixed-citation publication-type="journal"><name><surname>Horton</surname><given-names>NJ</given-names></name>, <name><surname>Kim</surname><given-names>E</given-names></name>, <name><surname>Saitz</surname><given-names>R</given-names></name>, <year>2007</year>. <article-title>A cautionary note regarding count models of alcohol consumption in randomized controlled trials</article-title>. <source>BMC Med. Res. Methodol</source><volume>7</volume>, <fpage>9</fpage>.<pub-id pub-id-type="pmid">17302984</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <mixed-citation publication-type="journal"><name><surname>Huis In ‘t Veld</surname><given-names>D</given-names></name>, <name><surname>Ensoy-Musoro</surname><given-names>C</given-names></name>, <name><surname>Pengpid</surname><given-names>S</given-names></name>, <name><surname>Peltzer</surname><given-names>K</given-names></name>, <name><surname>Colebunders</surname><given-names>R</given-names></name>, <year>2019</year>. <article-title>The efficacy of a brief intervention to reduce alcohol use in persons with HIV in South Africa, a randomized clinical trial</article-title>. <source>PloS One</source><volume>14</volume> (<issue>8</issue>), <fpage>e0220799</fpage>.<pub-id pub-id-type="pmid">31430313</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>J</given-names></name>, <name><surname>Jones</surname><given-names>M</given-names></name>, <name><surname>Plate</surname><given-names>C</given-names></name>, <name><surname>Lewis</surname><given-names>D</given-names></name>, <year>2011</year>. <article-title>The detection of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol in human dried blood spots</article-title>. <source>Anal. Methods</source><volume>3</volume> (<issue>5</issue>), <fpage>1101</fpage>.</mixed-citation>
              </ref>
              <ref id="R21">
                <mixed-citation publication-type="journal"><name><surname>Juszczak</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Hopewell</surname><given-names>S</given-names></name>, <name><surname>Schulz</surname><given-names>K</given-names></name>, <year>2019</year>. <article-title>Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement</article-title>. <source>JAMA</source><volume>321</volume> (<issue>16</issue>), <fpage>1610</fpage>–<lpage>1620</lpage>.<pub-id pub-id-type="pmid">31012939</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <mixed-citation publication-type="journal"><name><surname>Kane</surname><given-names>JC</given-names></name>, <name><surname>Sharma</surname><given-names>A</given-names></name>, <name><surname>Murray</surname><given-names>LK</given-names></name>, <name><surname>Chander</surname><given-names>G</given-names></name>, <name><surname>Kanguya</surname><given-names>T</given-names></name>, <name><surname>Skavenski</surname><given-names>S</given-names></name>, <name><surname>Chitambi</surname><given-names>C</given-names></name>, <name><surname>Lasater</surname><given-names>ME</given-names></name>, <name><surname>Paul</surname><given-names>R</given-names></name>, <name><surname>Cropsey</surname><given-names>K</given-names></name>, <name><surname>Inoue</surname><given-names>S</given-names></name>, <name><surname>Bosomprah</surname><given-names>S</given-names></name>, <name><surname>Danielson</surname><given-names>CK</given-names></name>, <name><surname>Chipungu</surname><given-names>J</given-names></name>, <name><surname>Simenda</surname><given-names>F</given-names></name>, <name><surname>Vinikoor</surname><given-names>MJ</given-names></name>, <year>2022</year>. <article-title>Efficacy of the Common Elements Treatment Approach (CETA) for unhealthy alcohol use among adults with HIV in Zambia: results from a pilot randomized controlled trial</article-title>. <source>AIDS Behav</source>. <volume>26</volume> (<issue>2</issue>), <fpage>523</fpage>–<lpage>536</lpage>.<pub-id pub-id-type="pmid">34328570</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <mixed-citation publication-type="journal"><name><surname>Lecher</surname><given-names>SL</given-names></name>, <name><surname>Fonjungo</surname><given-names>P</given-names></name>, <name><surname>Ellenberger</surname><given-names>D</given-names></name>, <name><surname>Toure</surname><given-names>CA</given-names></name>, <name><surname>Alemnji</surname><given-names>G</given-names></name>, <name><surname>Bowen</surname><given-names>N</given-names></name>, <name><surname>Basiye</surname><given-names>F</given-names></name>, <name><surname>Beukes</surname><given-names>A</given-names></name>, <name><surname>Carmona</surname><given-names>S</given-names></name>, <name><surname>de Klerk</surname><given-names>M</given-names></name>, <name><surname>Diallo</surname><given-names>K</given-names></name>, <name><surname>Dziuban</surname><given-names>E</given-names></name>, <name><surname>Kiyaga</surname><given-names>C</given-names></name>, <name><surname>Mbah</surname><given-names>H</given-names></name>, <name><surname>Mengistu</surname><given-names>J</given-names></name>, <name><surname>Mots’oane</surname><given-names>T</given-names></name>, <name><surname>Mwangi</surname><given-names>C</given-names></name>, <name><surname>Mwangi</surname><given-names>JW</given-names></name>, <name><surname>Mwasekaga</surname><given-names>M</given-names></name>, <name><surname>N’Tale</surname><given-names>J</given-names></name>, <name><surname>Naluguza</surname><given-names>M</given-names></name>, <name><surname>Ssewanyana</surname><given-names>I</given-names></name>, <name><surname>Stevens</surname><given-names>W</given-names></name>, <name><surname>Zungu</surname><given-names>I</given-names></name>, <name><surname>Bhairavabhotla</surname><given-names>R</given-names></name>, <name><surname>Chun</surname><given-names>H</given-names></name>, <name><surname>Gaffga</surname><given-names>N</given-names></name>, <name><surname>Jadczak</surname><given-names>S</given-names></name>, <name><surname>Lloyd</surname><given-names>S</given-names></name>, <name><surname>Nguyen</surname><given-names>S</given-names></name>, <name><surname>Pati</surname><given-names>R</given-names></name>, <name><surname>Sleeman</surname><given-names>K</given-names></name>, <name><surname>Zeh</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>G</given-names></name>, <name><surname>Alexander</surname><given-names>H</given-names></name>, <year>2021</year>. <article-title>HIV viral load monitoring among patients receiving antiretroviral therapy - eight Sub-Saharan Africa countries, 2013–2018</article-title>. <source>MMWR Morb. Mortal. Wkly Rep</source><volume>70</volume> (<issue>21</issue>), <fpage>775</fpage>–<lpage>778</lpage>.<pub-id pub-id-type="pmid">34043612</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <mixed-citation publication-type="journal"><name><surname>Leddy</surname><given-names>AM</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Getahun</surname><given-names>M</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Woolf-King</surname><given-names>SE</given-names></name>, <name><surname>Sanyu</surname><given-names>N</given-names></name>, <name><surname>Katusiime</surname><given-names>A</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Chander</surname><given-names>G</given-names></name>, <name><surname>Hutton</surname><given-names>HE</given-names></name>, <name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Camlin</surname><given-names>CS</given-names></name>, <year>2021</year>. <article-title>Cultural adaptation of an intervention to reduce hazardous alcohol use among people living with HIV in southwestern Uganda</article-title>. <source>AIDS Behav</source>. <volume>25</volume> (<issue>Suppl 3</issue>), <fpage>237</fpage>–<lpage>250</lpage>.</mixed-citation>
              </ref>
              <ref id="R25">
                <mixed-citation publication-type="journal"><name><surname>Luginbühl</surname><given-names>M</given-names></name>, <name><surname>Wurst</surname><given-names>FM</given-names></name>, <name><surname>Stöth</surname><given-names>F</given-names></name>, <name><surname>Weinmann</surname><given-names>W</given-names></name>, <name><surname>Stove</surname><given-names>CP</given-names></name>, <name><surname>Van Uytfanghe</surname><given-names>K</given-names></name>, <year>2022</year>. <article-title>Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)</article-title>. <source>Drug Test. Anal</source></mixed-citation>
              </ref>
              <ref id="R26">
                <mixed-citation publication-type="journal"><name><surname>Madhombiro</surname><given-names>M</given-names></name>, <name><surname>Musekiwa</surname><given-names>A</given-names></name>, <name><surname>January</surname><given-names>J</given-names></name>, <name><surname>Chingono</surname><given-names>A</given-names></name>, <name><surname>Abas</surname><given-names>M</given-names></name>, <name><surname>Seedat</surname><given-names>S</given-names></name>, <year>2019</year>. <article-title>Psychological interventions for alcohol use disorders in people living with HIV/AIDS: a systematic review</article-title>. <source>Syst. Rev</source><volume>8</volume> (<issue>1</issue>), <fpage>244</fpage>.<pub-id pub-id-type="pmid">31661030</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <mixed-citation publication-type="journal"><name><surname>Madhombiro</surname><given-names>M</given-names></name>, <name><surname>Kidd</surname><given-names>M</given-names></name>, <name><surname>Dube</surname><given-names>B</given-names></name>, <name><surname>Dube</surname><given-names>M</given-names></name>, <name><surname>Mutsvuke</surname><given-names>W</given-names></name>, <name><surname>Muronzie</surname><given-names>T</given-names></name>, <name><surname>Zhou</surname><given-names>DT</given-names></name>, <name><surname>Derveeuw</surname><given-names>S</given-names></name>, <name><surname>Chibanda</surname><given-names>D</given-names></name>, <name><surname>Chingono</surname><given-names>A</given-names></name>, <name><surname>Rusakaniko</surname><given-names>S</given-names></name>, <name><surname>Hutson</surname><given-names>A</given-names></name>, <name><surname>Morse</surname><given-names>GD</given-names></name>, <name><surname>Abas</surname><given-names>MA</given-names></name>, <name><surname>Seedat</surname><given-names>S</given-names></name>, <year>2020</year>. <article-title>Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial</article-title>. <source>J. Int AIDS Soc</source><volume>23</volume> (<issue>12</issue>), <fpage>e25641</fpage>.<pub-id pub-id-type="pmid">33314786</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <mixed-citation publication-type="journal"><name><surname>Magidson</surname><given-names>JF</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Orrell</surname><given-names>C</given-names></name>, <name><surname>Amanyire</surname><given-names>G</given-names></name>, <name><surname>Haberer</surname><given-names>JE</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <year>2019</year>. <article-title>Biomarker-measured unhealthy alcohol use in relation to CD4 count among individuals starting ART in Sub-Saharan Africa</article-title>. <source>AIDS Behav</source>. <volume>23</volume> (<issue>6</issue>), <fpage>1656</fpage>–<lpage>1667</lpage>.<pub-id pub-id-type="pmid">30560484</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <mixed-citation publication-type="journal"><name><surname>Magidson</surname><given-names>JF</given-names></name>, <name><surname>Joska</surname><given-names>JA</given-names></name>, <name><surname>Belus</surname><given-names>JM</given-names></name>, <name><surname>Andersen</surname><given-names>LS</given-names></name>, <name><surname>Regenauer</surname><given-names>KS</given-names></name>, <name><surname>Rose</surname><given-names>AL</given-names></name>, <name><surname>Myers</surname><given-names>B</given-names></name>, <name><surname>Majokweni</surname><given-names>S</given-names></name>, <name><surname>O’Cleirigh</surname><given-names>C</given-names></name>, <name><surname>Safren</surname><given-names>SA</given-names></name>, <year>2021</year>. <article-title>Project Khanya: results from a pilot randomized type 1 hybrid effectiveness-implementation trial of a peer-delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa</article-title>. <source>J. Int AIDS Soc</source><volume>24</volume><comment>Suppl 2</comment> (<issue>Suppl 2</issue>), <fpage>e25720</fpage>.<pub-id pub-id-type="pmid">34164935</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <mixed-citation publication-type="journal"><name><surname>Manning</surname><given-names>WG</given-names></name>, <name><surname>Mullahy</surname><given-names>J</given-names></name>, <year>2001</year>. <article-title>Estimating log models: to transform or not to transform?</article-title><source>J. Health Econ</source><volume>20</volume> (<issue>4</issue>), <fpage>461</fpage>–<lpage>494</lpage>.<pub-id pub-id-type="pmid">11469231</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <mixed-citation publication-type="journal"><name><surname>McCambridge</surname><given-names>J</given-names></name>, <name><surname>Saitz</surname><given-names>R</given-names></name>, <year>2017</year>. <article-title>Rethinking brief interventions for alcohol in general practice</article-title>. <source>BMJ</source><volume>356</volume>, <fpage>j116</fpage>.<pub-id pub-id-type="pmid">28108452</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <mixed-citation publication-type="journal"><name><surname>McGinnis</surname><given-names>KA</given-names></name>, <name><surname>Tate</surname><given-names>JP</given-names></name>, <name><surname>Bryant</surname><given-names>KJ</given-names></name>, <name><surname>Justice</surname><given-names>AC</given-names></name>, <name><surname>O’Connor</surname><given-names>PG</given-names></name>, <name><surname>Rodriguez-Barradas</surname><given-names>MC</given-names></name>, <name><surname>Crystal</surname><given-names>S</given-names></name>, <name><surname>Cutter</surname><given-names>CJ</given-names></name>, <name><surname>Hansen</surname><given-names>NB</given-names></name>, <name><surname>Maisto</surname><given-names>SA</given-names></name>, <name><surname>Marconi</surname><given-names>VC</given-names></name>, <name><surname>Williams</surname><given-names>EC</given-names></name>, <name><surname>Cook</surname><given-names>RL</given-names></name>, <name><surname>Gordon</surname><given-names>AJ</given-names></name>, <name><surname>Gordon</surname><given-names>KS</given-names></name>, <name><surname>Eyawo</surname><given-names>O</given-names></name>, <name><surname>Edelman</surname><given-names>EJ</given-names></name>, <name><surname>Fiellin</surname><given-names>DA</given-names></name>, <year>2021</year>. <article-title>Change in alcohol use based on self-report and a quantitative biomarker, phosphatidylethanol, in people With HIV</article-title>. <source>AIDS Behav</source>.</mixed-citation>
              </ref>
              <ref id="R33">
                <mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>NS</given-names></name>, <name><surname>MacLean</surname><given-names>CD</given-names></name>, <name><surname>Chew</surname><given-names>LD</given-names></name>, <name><surname>Littenberg</surname><given-names>B</given-names></name>, <year>2006</year>. <article-title>The single item literacy screener: evaluation of a brief instrument to identify limited reading ability</article-title>. <source>BMC Fam. Pr</source><volume>7</volume>, <fpage>21</fpage>.</mixed-citation>
              </ref>
              <ref id="R34">
                <mixed-citation publication-type="journal"><name><surname>Muyindike</surname><given-names>WR</given-names></name>, <name><surname>Lloyd-Travaglini</surname><given-names>C</given-names></name>, <name><surname>Fatch</surname><given-names>R</given-names></name>, <name><surname>Emenyonu</surname><given-names>NI</given-names></name>, <name><surname>Adong</surname><given-names>J</given-names></name>, <name><surname>Ngabirano</surname><given-names>C</given-names></name>, <name><surname>Cheng</surname><given-names>DM</given-names></name>, <name><surname>Winter</surname><given-names>MR</given-names></name>, <name><surname>Samet</surname><given-names>JH</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <year>2017</year>. <article-title>Phosphatidylethanol confirmed alcohol use among ART-naive HIV-infected persons who denied consumption in rural Uganda</article-title>. <source>AIDS Care</source><fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
              </ref>
              <ref id="R35">
                <mixed-citation publication-type="journal"><name><surname>Pantalon</surname><given-names>MV</given-names></name>, <name><surname>Martino</surname><given-names>S</given-names></name>, <name><surname>Dziura</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>FY</given-names></name>, <name><surname>Owens</surname><given-names>PH</given-names></name>, <name><surname>Fiellin</surname><given-names>DA</given-names></name>, <name><surname>O’Connor</surname><given-names>PG</given-names></name>, <name><surname>D’Onofrio</surname><given-names>G</given-names></name>, <year>2012</year>. <article-title>Development of a scale to measure practitioner adherence to a brief intervention in the emergency department</article-title>. <source>J. Subst. Abus. Treat</source><volume>43</volume> (<issue>4</issue>), <fpage>382</fpage>–<lpage>388</lpage>.</mixed-citation>
              </ref>
              <ref id="R36">
                <mixed-citation publication-type="journal"><name><surname>Papas</surname><given-names>RK</given-names></name>, <name><surname>Gakinya</surname><given-names>BN</given-names></name>, <name><surname>Mwaniki</surname><given-names>MM</given-names></name>, <name><surname>Keter</surname><given-names>AK</given-names></name>, <name><surname>Lee</surname><given-names>H</given-names></name>, <name><surname>Loxley</surname><given-names>MP</given-names></name>, <name><surname>Klein</surname><given-names>DA</given-names></name>, <name><surname>Sidle</surname><given-names>JE</given-names></name>, <name><surname>Martino</surname><given-names>S</given-names></name>, <name><surname>Baliddawa</surname><given-names>JB</given-names></name>, <name><surname>Schlaudt</surname><given-names>KL</given-names></name>, <name><surname>Maisto</surname><given-names>SA</given-names></name>, <year>2016</year>. <article-title>Associations between the phosphatidylethanol alcohol biomarker and self-reported alcohol use in a sample of HIV-infected outpatient drinkers in western Kenya</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>40</volume> (<issue>8</issue>), <fpage>1779</fpage>–<lpage>1787</lpage>.<pub-id pub-id-type="pmid">27426424</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <mixed-citation publication-type="journal"><name><surname>Papas</surname><given-names>RK</given-names></name>, <name><surname>Gakinya</surname><given-names>BN</given-names></name>, <name><surname>Mwaniki</surname><given-names>MM</given-names></name>, <name><surname>Lee</surname><given-names>H</given-names></name>, <name><surname>Keter</surname><given-names>AK</given-names></name>, <name><surname>Martino</surname><given-names>S</given-names></name>, <name><surname>Klein</surname><given-names>DA</given-names></name>, <name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Loxley</surname><given-names>MP</given-names></name>, <name><surname>Sidle</surname><given-names>JE</given-names></name>, <name><surname>Schlaudt</surname><given-names>K</given-names></name>, <name><surname>Nafula</surname><given-names>T</given-names></name>, <name><surname>Omodi</surname><given-names>VM</given-names></name>, <name><surname>Baliddawa</surname><given-names>JB</given-names></name>, <name><surname>Kinyanjui</surname><given-names>DW</given-names></name>, <name><surname>Maisto</surname><given-names>SA</given-names></name>, <year>2021</year>. <article-title>A randomized clinical trial of a group cognitive-behavioral therapy to reduce alcohol use among human immunodeficiency virus-infected outpatients in western Kenya</article-title>. <source>Addiction</source><volume>116</volume> (<issue>2</issue>), <fpage>305</fpage>–<lpage>318</lpage>.<pub-id pub-id-type="pmid">32422685</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <mixed-citation publication-type="other"><name><surname>Rubin</surname><given-names>M</given-names></name>, <year>2016</year>. <source>The Perceived Awareness of the Research Hypothesis Scale: Assessing the influence of demand characteristics</source>.</mixed-citation>
              </ref>
              <ref id="R39">
                <mixed-citation publication-type="journal"><name><surname>Rubinsky</surname><given-names>AD</given-names></name>, <name><surname>Dawson</surname><given-names>DA</given-names></name>, <name><surname>Williams</surname><given-names>EC</given-names></name>, <name><surname>Kivlahan</surname><given-names>DR</given-names></name>, <name><surname>Bradley</surname><given-names>KA</given-names></name>, <year>2013</year>. <article-title>AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>37</volume> (<issue>8</issue>), <fpage>1380</fpage>–<lpage>1390</lpage>.<pub-id pub-id-type="pmid">23906469</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <mixed-citation publication-type="journal"><name><surname>Saitz</surname><given-names>R</given-names></name>, <name><surname>Miller</surname><given-names>SC</given-names></name>, <name><surname>Fiellin</surname><given-names>DA</given-names></name>, <name><surname>Rosenthal</surname><given-names>RN</given-names></name>, <year>2021</year>. <article-title>Recommended use of terminology in addiction medicine</article-title>. <source>J. Addict. Med</source><volume>15</volume> (<issue>1</issue>), <fpage>3</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">32482955</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <mixed-citation publication-type="journal"><name><surname>Sankoh</surname><given-names>O</given-names></name>, <name><surname>Sevalie</surname><given-names>S</given-names></name>, <name><surname>Weston</surname><given-names>M</given-names></name>, <year>2018</year>. <article-title>Mental health in Africa</article-title>. <source>Lancet Glob. Health</source><volume>6</volume> (<issue>9</issue>), <fpage>e954</fpage>–<lpage>e955</lpage>.<pub-id pub-id-type="pmid">30103990</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <mixed-citation publication-type="journal"><name><surname>Satre</surname><given-names>DD</given-names></name>, <name><surname>Sarovar</surname><given-names>V</given-names></name>, <name><surname>Leyden</surname><given-names>W</given-names></name>, <name><surname>Hare</surname><given-names>CB</given-names></name>, <name><surname>Catz</surname><given-names>SL</given-names></name>, <name><surname>Bryant</surname><given-names>KJ</given-names></name>, <name><surname>Williams</surname><given-names>EC</given-names></name>, <name><surname>Hojilla</surname><given-names>JC</given-names></name>, <name><surname>Horberg</surname><given-names>MA</given-names></name>, <name><surname>Silverberg</surname><given-names>MJ</given-names></name>, <year>2020</year>. <article-title>Changes in days of unhealthy alcohol use and antiretroviral therapy adherence, HIV RNA levels, and condomless sex: a secondary analysis of clinical trial data</article-title>. <source>AIDS Behav</source>. <volume>24</volume> (<issue>6</issue>), <fpage>1784</fpage>–<lpage>1792</lpage>.<pub-id pub-id-type="pmid">31773444</pub-id></mixed-citation>
              </ref>
              <ref id="R43">
                <mixed-citation publication-type="journal"><name><surname>Scott-Sheldon</surname><given-names>LAJ</given-names></name>, <name><surname>Carey</surname><given-names>KB</given-names></name>, <name><surname>Johnson</surname><given-names>BT</given-names></name>, <name><surname>Carey</surname><given-names>MP</given-names></name>, <name><surname>Team</surname><given-names>MR</given-names></name>, <year>2017</year>. <article-title>Behavioral interventions targeting alcohol use among people living with HIV/AIDS: a systematic review and meta-analysis</article-title>. <source>AIDS Behav</source>. <volume>21</volume> (<issue>Suppl 2</issue>), <fpage>126</fpage>–<lpage>143</lpage>.<pub-id pub-id-type="pmid">28831609</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <mixed-citation publication-type="journal"><name><surname>Singla</surname><given-names>DR</given-names></name>, <name><surname>Weobong</surname><given-names>B</given-names></name>, <name><surname>Nadkarni</surname><given-names>A</given-names></name>, <name><surname>Chowdhary</surname><given-names>N</given-names></name>, <name><surname>Shinde</surname><given-names>S</given-names></name>, <name><surname>Anand</surname><given-names>A</given-names></name>, <name><surname>Fairburn</surname><given-names>CG</given-names></name>, <name><surname>Dimijdan</surname><given-names>S</given-names></name>, <name><surname>Velleman</surname><given-names>R</given-names></name>, <name><surname>Weiss</surname><given-names>H</given-names></name>, <name><surname>Patel</surname><given-names>V</given-names></name>, <year>2014</year>. <article-title>Improving the scalability of psychological treatments in developing countries: an evaluation of peer-led therapy quality assessment in Goa, India</article-title>. <source>Behav. Res. Ther</source><volume>60</volume>, <fpage>53</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">25064211</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <mixed-citation publication-type="book"><name><surname>Sobell</surname><given-names>LC</given-names></name>, <name><surname>Sobell</surname><given-names>MB</given-names></name>, <year>1992</year>. <part-title>Timeline follow-back: a technique for assessing self-reported ethanol consumption</part-title>. In: <name><surname>Allen</surname><given-names>J</given-names></name>, <name><surname>Litten</surname><given-names>RZ</given-names></name> (Eds.), <source>Measuring Alcohol Consumption: Psychosocial and Biological Methods</source>. <publisher-name>Humana Press</publisher-name>, <publisher-loc>Totowa, NJ</publisher-loc>.</mixed-citation>
              </ref>
              <ref id="R46">
                <mixed-citation publication-type="journal"><name><surname>Ulwelling</surname><given-names>W</given-names></name>, <name><surname>Smith</surname><given-names>K</given-names></name>, <year>2018</year>. <article-title>The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines</article-title>. <source>J. Forensic Sci</source><volume>63</volume> (<issue>6</issue>), <fpage>1634</fpage>–<lpage>1640</lpage>.<pub-id pub-id-type="pmid">30005144</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <mixed-citation publication-type="journal"><name><surname>Wandera</surname><given-names>B</given-names></name>, <name><surname>Tumwesigye</surname><given-names>NM</given-names></name>, <name><surname>Nankabirwa</surname><given-names>JI</given-names></name>, <name><surname>Mafigiri</surname><given-names>DK</given-names></name>, <name><surname>Parkes-Ratanshi</surname><given-names>RM</given-names></name>, <name><surname>Kapiga</surname><given-names>S</given-names></name>, <name><surname>Hahn</surname><given-names>J</given-names></name>, <name><surname>Sethi</surname><given-names>AK</given-names></name>, <year>2016</year>. <article-title>Efficacy of a single, brief alcohol reduction intervention among men and women living with HIV/AIDS and using alcohol in Kampala, Uganda: a randomized trial</article-title>. <source>J. Int Assoc. Provid AIDS Care</source></mixed-citation>
              </ref>
              <ref id="R48">
                <mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>EC</given-names></name>, <name><surname>Hahn</surname><given-names>JA</given-names></name>, <name><surname>Saitz</surname><given-names>R</given-names></name>, <name><surname>Bryant</surname><given-names>K</given-names></name>, <name><surname>Lira</surname><given-names>MC</given-names></name>, <name><surname>Samet</surname><given-names>JH</given-names></name>, <year>2016</year>. <article-title>Alcohol use and human immunodeficiency virus (HIV) infection: current knowledge, implications, and future directions</article-title>. <source>Alcohol Clin. Exp. Res</source><volume>40</volume> (<issue>10</issue>), <fpage>2056</fpage>–<lpage>2072</lpage>.<pub-id pub-id-type="pmid">27696523</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="F1">
              <label>Fig. 1.</label>
              <caption>
                <p id="P50">Consort diagram for randomized controlled trial of two brief alcohol interventions versus a control. <italic toggle="yes">See attached.</italic></p>
              </caption>
              <graphic xlink:href="nihms-1920815-f0001" position="float"/>
            </fig>
            <fig position="float" id="F2">
              <label>Fig. 2.</label>
              <caption>
                <p id="P51">Primary outcomes by study arm over study months. A) Mean self-reported number of drinking days (NDD), prior 21, with 95 % confidence intervals. B) Mean phosphatidylethanol (PEth) ng/mL with 95 % confidence intervals.</p>
              </caption>
              <graphic xlink:href="nihms-1920815-f0002" position="float"/>
            </fig>
            <table-wrap position="float" id="T1" orientation="landscape">
              <label>Table 1</label>
              <caption>
                <p id="P52">Baseline characteristics, overall and by study arm.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th rowspan="2" align="left" valign="top" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">Overall (n = 269)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Control arm (n = 89)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Live call arm (n = 90)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Technology arm (n = 90)</th>
                  </tr>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1">n (%)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">n (%)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">n (%)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">n (%)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Sex</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Female</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">93 (34.6 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30 (33.7 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33 (36.7 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30 (33.3 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Male</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">176 (65.4 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">59 (66.3 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">57 (63.3 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">60 (66.7 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Literate/somewhat literate</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> No</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">37 (13.8 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">15 (17.1 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9 (10.0 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">13 (14.4 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Yes</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">231 (86.2 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">73 (83.0 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">81 (90.0 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">77 (85.6 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Virally suppressed</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">No</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29 (10.8 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8 (9.0 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">13 (14.4 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8 (8.9 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Yes (&lt;40 copies/mm<sup>3</sup>)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">240 (89.2 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">81 (91.0 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">77 (85.6 %)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">82 (91.1 %)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Mean (95 % CI)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Mean (95 % CI)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Mean (95 % CI)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Age</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">50.2 (39.1−41.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">40.2 (38.1−42.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">40.7 (38.6−42.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39.8 (37.9−41.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Years since HIV diagnosis (n = 248)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8.9 (8.2−9.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9.3 (8.1−10.4)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9.3 (8.0−10.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8.2 (7.1−9.2)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Years since ART initiation (n = 240)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.3 (6.7−7.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.8 (6.8−8.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.1 (5.9−8.2)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.0 (6.1−7.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Social desirability score</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.4 (18.0−18.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.2 (17.5−18.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.1 (17.4−18.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.9 (18.2−19.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Number of drinking days, past 21</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9.4 (9.1−9.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9.2 (8.6−9.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8.8 (8.2−9.5)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10.3 (9.6−11.0)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">PEth (ng/mL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">407.8 (340.7−474.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">413.3 (306.6−519.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">303.9 (230.7−377.1)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">506.2 (351.8−660.5)</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="T2" orientation="landscape">
              <label>Table 2</label>
              <caption>
                <p id="P53">Intervention uptake and satisfaction, overall and by intervention arm.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">Overall</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Control</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Live Call</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Technology</th>
                  </tr>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">(n = 269)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">(n = 89)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">(n = 90)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">(n = 90)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">
                      <bold>Counseling sessions</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">% completed in-person session 1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 %</td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">Length of session 1 (minutes), mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">69.8 (68.2−71.4)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">69.9 (67.3−72.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">69.6 (67.7−71.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% completed in-person session 2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">96.1 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">97.8 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">94.4 %</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% brought helper to session 2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39.3 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">43.2 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">35.3 %</td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">Length of session 2 (minutes), mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">43.8 (41.9−45.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">45.2 (41.8−48.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">42.3 (40.6−44.0)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Fidelity checklist %, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 % (100.0−100.0) (n = 37)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 % (100.0−100.0) (n = 18)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100.0 % (100.0−100.0) (n = 19)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Counseling skills %, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">95.7 % (94.2−97.3) (n = 37)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">94.0 % (91.4−96.6) (n = 18)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">97.4 % (95.7−99.0) (n = 19)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Booster sessions</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1"># attempted per participant, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.2 (3.1−3.4)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">23.5 (22.3−24.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% completed per participant, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1">86.5 % (81.8−91.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">44.7 % (33.4−51.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">Length of booster calls (minutes), mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.4 (6.2−6.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Intervention satisfaction</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Client Satisfaction Questionnaire – 8, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">92.1 (91.2−93.0) (n = 254)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">90.0 (88.2−91.8) (n = 85)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">93.3 (91.9−94.8) (n = 83)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">93.1 (91.8−94.5) (n = 86)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">System Usability Scale, mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">34.9 (34.2−35.5) (n = 86)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="bottom" rowspan="1" colspan="1">Thought the researchers were studying:</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">(n = 254)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">(n = 85)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">(n = 83)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">(n = 86)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Ways to quit/reduce alcohol use</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">71.3 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">67.1 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">66.3 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">80.2 %</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Ways to improve health</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22.1 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">23.5 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">26.5 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">16.3 %</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1"> Ways to improve taking medications</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.7 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9.4 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.2 %</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.5 %</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="T3">
              <label>Table 3</label>
              <caption>
                <p id="P54">Primary outcomes by study arm for each study visit, unadjusted results.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="middle" rowspan="1" colspan="1"/>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Control arm</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Live call arm</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Technology arm</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Number of drinking days, prior 21, mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9.2 (8.6–9.9)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">8.8 (8.2–9.5)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">10.3 (9.6–11.0)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3–month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.5 (5.0–6.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.7 (3.3–4.2)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.2 (2.8–3.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.5 (5.0–6.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.9 (2.6–3.3)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.0 (2.6–3.4)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.5 (5.0–6.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.2 (1.9–2.5)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.8 (2.4–3.1)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>PEth ng/mL, mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">413.3 (306.6–519.9)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">303.9 (230.7–377.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">506.2 (351.8–660.5)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">380.5 (278.0–483.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">338.0 (242.8–433.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">427.0 (314.7–539.4)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">396.9 (290.5–503.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">376.9 (259.6–494.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">506.2 (386.1–626.3)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">396.2 (288.1–504.3)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">313.8 (220.3–407.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">500.8 (340.2–661.3)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Viral suppression, % (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">91.0 % (83.1–96.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">85.6 % (76.6–92.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">91.1 % (83.2–96.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">92.9 % (85.1–97.3)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">95.0 % (87.7–98.6)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">94.1 % (86.7–98.0)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p id="P55">Viral load tested at baseline and nine months.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="T4">
              <label>Table 4</label>
              <caption>
                <p id="P56">Estimated means and 95 % confidence intervals at follow up, difference in means compared to the control, and p-values for primary outcomes from regression models adjusted for sex and the baseline value of each outcome.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Control</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Live call</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Technology</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>Number of drinking days, prior 21</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.2 (4.8–7.5)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.7 (2.0–3.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.5 (2.0–3.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.5 (2.1–4.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.6 (2.2–5.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>PEth (ng/mL)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">528.6 (397.3–659.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">492.2 (369.1–615.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">559.5 (426.7–692.3)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36.4 (−117.5 to 190.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−30.9 (−194.8 to 132.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.643</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.711</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Viral suppression</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">92.9 % (87.5–98.2)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">95.2 % (90.7–99.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">93.8 % (88.7–98.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−2.3 % (−9.3 to 4.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−0.9 % (−8.3 to 6.4)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.515</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.801</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="T5">
              <label>Table 5</label>
              <caption>
                <p id="P57">Secondary outcomes by study month for each month, unadjusted results.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="middle" rowspan="1" colspan="1"/>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Control arm</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Live call arm</th>
                    <th align="left" valign="middle" rowspan="1" colspan="1">Technology arm</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Number of heavy drinking days (&gt; 3 drinks per day for women and &gt; 4 drinks per day for men) prior 21, mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6.0 (5.5–6.5)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">4.9 (4.4–5.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.7 (5.2–6.2)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.8 (2.5–3.2)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.9 (0.7–1.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1.5 (1.2–1.8)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.6 (3.2–4.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1.2 (1.0–1.5)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1.4 (1.1–1.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.3 (2.9–3.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">0.6 (0.5–0.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">1.5 (1.3–1.8)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>AUDIT-C (prior 3 months) score (0–12), mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">7.1 (6.5–7.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6.8 (6.2–7.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6.9 (6.3–7.5)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.6 (4.8–6.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.1 (2.5–3.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3.5 (2.8–4.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">5.3 (4.6–6.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.7 (2.2–3.3)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">2.9 (2.2–3.5)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Unhealthy alcohol use via AUDIT-C</bold>
                      <xref rid="TFN2" ref-type="table-fn">*</xref>
                      <bold>, % (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">95.5 % (88.8–98.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">96.7 % (90.6–99.3)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">97.8 % (92.2–99.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">66.7 % (55.5–76.6)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">43.4 % (32.5–54.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">46.5 % (35.7–57.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">69.0 % (58.0–78.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">32.9 % (23.1–44.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">40.2 % (29.9–51.3)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>PEth ≥ 50 ng/mL, % (95 % CI)</bold>
                    </td>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                    <td align="left" valign="middle" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">77.5 % (67.4–85.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">77.8 % (67.8–85.9)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">86.7 % (77.9–92.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">3-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">74.0 % (62.8–83.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">73.9 % (63.4–82.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">81.2 % (71.2–88.8)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">78.6 % (68.3–86.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">72.3 % (61.4–81.6)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">83.7 % (74.2–90.8)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">78.6 % (68.3–86.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">72.9 % (62.2–82.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">86.2 % (77.1–92.7)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Unhealthy alcohol use via AUDIT-C</bold>
                      <xref rid="TFN2" ref-type="table-fn">*</xref>
                      <bold>and/or PEth ≥ 50 ng/mL, % (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">100.0 % (95.9–100.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">97.8 % (92.2–99.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">98.9 % (94.0–100.0)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">90.6 % (82.3–95.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">78.3 % (67.9–86.6)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">89.5 % (81.1–95.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">88.1 % (79.2–94.1)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">78.8 % (68.6–86.9)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">87.4 % (78.5–93.5)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>ART adherence, mean % (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">88.7 % (86.0–91.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">90.0 % (87.2–92.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">86.4 % (82.2–90.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">90.4 % (88.2–92.7)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">92.3 % (89.4–95.2)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">91.6 % (88.4–94.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">92.8 % (91.0–94.5)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">93.3 % (91.3–95.4)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">93.3 % (90.3–96.2)</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="middle" rowspan="1">
                      <bold>Social Desirability Score (SDS), mean (95 % CI)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Baseline</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">18.2 (17.5–18.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">18.1 (17.4–18.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">18.9 (18.2–19.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">6-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">19.1 (18.4–19.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">19.0 (18.3–19.8)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">19.5 (18.7–20.3)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">9-month</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">21.3 (20.6–22.0)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">21.2 (20.5–21.9)</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">22.0 (21.3–22.7)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN2">
                  <label>*</label>
                  <p id="P58">Prior 3 months, ≥ 3 for women, ≥ 4 for men</p>
                </fn>
                <fn id="TFN3">
                  <p id="P59">AUDIT-C and SDS, and ART adherence measured at baseline, six, and nine months.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="T6">
              <label>Table 6</label>
              <caption>
                <p id="P60">Estimated means and 95 % confidence intervals at follow up, difference in means compared to the control, and p-values for secondary outcomes from regression models adjusted for sex and the baseline value of each outcome.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">Control</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Live call</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Technology</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>Number of heavy drinking days (&gt; 3 drinks per day for women and &gt; 4 drinks per day for men) prior 21</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">5.8 (2.8–8.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.4 (0.6–2.1)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.5 (0.7–2.3)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.4 (1.6–7.3)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.3 (1.5–7.2)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.002</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.003</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>AUDIT-C (prior 3 months) score (0–12)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">5.4 (4.8–5.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.0 (2.5–3.5)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.2 (2.7–3.7)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.3 (1.6–3.0)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.2 (1.5–2.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>Unhealthy alcohol use via AUDIT-C</bold>
                      <xref rid="TFN4" ref-type="table-fn">*</xref>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">67.7 % (59.8–75.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">38.8 % (30.1–47.5)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">42.8 % (34.0–51.6)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.9 % (17.0–40.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24.9 % (13.0–36.8)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>PEth ≥ 50 ng/mL</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">77.1 % (70.8–83.4)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">72.8 % (66.2–79.4)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">81.1 % (74.7–87.4)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.3 % (−4.0 to 12.6)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−4.0 % (−12.1 to 4.2)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.306</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.337</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>Unhealthy alcohol use via AUDIT-C</bold>
                      <xref rid="TFN4" ref-type="table-fn">*</xref>
                      <bold>and/or PEth ≥ 50 ng/mL (%)</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">% (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">88.4 % (82.7–94.1)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">79.7 % (72.5–86.9)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">88.5 % (82.7–94.3)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8.7 % (−0.5 to 18.0)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−0.1 % (−8.2 to 8.0)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.063</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.980</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>ART adherence %</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">91.6 (89.5–93.7)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">92.4 (90.3–94.5)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">92.7 (90.6–94.8)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−0.8 (−3.8 to 2.2)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−1.1 (−4.1 to 1.9)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.610</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.474</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="left" valign="top" rowspan="1">
                      <bold>Social Desirability Score (SDS)</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Mean (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20.3 (19.7–20.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20.2 (19.7–20.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20.6 (20.0–21.1)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Control minus Intervention arm (95 % CI)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.0 (−0.7 to 0.8)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">−0.3 (−1.0 to 0.5)</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">p-value</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">-</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.946</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.454</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN4">
                  <label>*</label>
                  <p id="P61">Prior 3 months, &gt; 3 for women, &gt; 4 for men</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
